C12N 5/0618
Cells of the nervous system
Official title: {Cells of the nervous system}
C12N5/0618 (Cells of the nervous system) appears on 1,844 US grants and 3,813 published applications in this corpus.
Search patents in C12N- Granted patents
- 1,844
- Published applications
- 3,813
- Assignees
- 1,325
- Inventors
- 6,393
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1987 | 2 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 2 | 0 |
| 1991 | 1 | 0 |
| 1992 | 5 | 0 |
| 1993 | 5 | 0 |
| 1994 | 9 | 0 |
| 1995 | 6 | 0 |
| 1996 | 9 | 0 |
| 1997 | 15 | 0 |
| 1998 | 25 | 0 |
| 1999 | 19 | 0 |
| 2000 | 29 | 0 |
| 2001 | 30 | 14 |
| 2002 | 20 | 69 |
| 2003 | 27 | 90 |
| 2004 | 27 | 85 |
| 2005 | 21 | 103 |
| 2006 | 38 | 110 |
| 2007 | 27 | 95 |
| 2008 | 30 | 99 |
| 2009 | 46 | 93 |
| 2010 | 47 | 96 |
| 2011 | 37 | 105 |
| 2012 | 62 | 157 |
| 2013 | 59 | 115 |
| 2014 | 82 | 125 |
| 2015 | 75 | 145 |
| 2016 | 83 | 179 |
| 2017 | 88 | 174 |
| 2018 | 94 | 173 |
| 2019 | 124 | 235 |
| 2020 | 106 | 196 |
| 2021 | 86 | 205 |
| 2022 | 90 | 228 |
| 2023 | 90 | 226 |
| 2024 | 111 | 283 |
| 2025 | 110 | 224 |
| 2026 | 107 | 189 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Induced pluripotent stem cell derived glial enriched progenitor cells for the treatment of white matter stroke6 Oct 2026US 12,751,976 B2The Regents of the University of California
- Composition for inducing direct cross differentiation of somatic cell into motor neuron, and method for using same6 Oct 2026US 12,753,385 B2Unist (Ulsan National Institute of Science and Technology)
- Production method for stage 5 neurons6 Oct 2026US 12,753,386 B2Ricoh Company, Ltd.
- Methods for manufacture of neuronal precursors6 Oct 2026US 12,753,387 B2Skin2Neuron Pty Ltd
- Complex microfluidic models for ALS including NF biomarkers for ALS research and drug development29 Sep 2026US 12,748,102 B2Cedars-Sinai Medical Center
- Intra-striatal co-transplantation of autologous treg and mda cells in parkinson's disease cell therapy8 Oct 2026US 2026/0306543 A1The McLean Hospital Corporation
- Retinal pigment epithelium cell therapy8 Oct 2026US 2026/0306548 A1The Regents of the University of California
- Chimeric organoids8 Oct 2026US 2026/0308513 A1President and Fellows of Harvard College
- Composition for cultivation of stem cells including substrate with controlled mechanical strength and use thereof8 Oct 2026US 2026/0308514 A1Ajou University Industry-Academic Cooperation Foundation
- Perfusion system for corneal endothelial cell graft evaluation1 Oct 2026US 2026/0293880 A1Regents of the University of Minnesota
Most cited
By later US patents
- Renewable neural implant device and method1,456US 5,554,148 ABrown University Research Foundation · 1996
- Biocompatible devices with foam scaffolds984US 6,054,142 ACyto Therapeutics, Inc. · 2000
- Serum-free, synthetic, completely chemically defined tissue culture media450US 4,657,866 A1987
- In vivo delivery of neurotransmitters by implanted, encapsulated cells398US 4,892,538 ABrown University Research Foundation · 1990
- Biocompatible devices with foam scaffolds353US 6,231,879 B1Neurotech S.A. · 2001